Loading…
Based on limited metadata, the FDA issued a warning letter to A C Calderoni & Co. Inc. on March 14, 2018, regarding products classified as "Other" — indicating they fall outside standard FDA product categories. Without access to the full warning letter text or subject line details, the specific nature of the regulatory violations cannot be determined from the available information. The issuing office is also unknown, which limits identification of the particular FDA division overseeing this enforcement action. A review of the complete warning letter would be necessary to understand the company's specific compliance failures and required corrective actions.